• Advancing regulatory pathway, fully secured supply chain, and growing commercial traction position the Company for scalable deployment across AI, industrial, and healthcare markets
     

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ:NKLR) ("Terra Innovatum" or the "Company"), developer of the SOLO™ Micro-Modular Reactor, today announced the release of an updated investor presentation highlighting continued progress across regulatory, manufacturing, and commercial initiatives, as well as an expanded set of high-value end-market opportunities.

The updated presentation will be featured in connection with Terra Innovatum's participation at the ROTH Conference, where management is presenting, participating in panel discussions, and hosting one-on-one investor meetings.

The updated materials underscore several important developments:

  • Advanced Regulatory Progress and Clear Licensing Pathway

    Terra continues to advance its engagement with the U.S. Nuclear Regulatory Commission (NRC), with multiple technical submissions completed and the pre-application phase nearing completion, supporting readiness for Construction Permit Application (CPA) submission
  • Design Completion and Fully Funded Path to First Deployment

    The SOLO™ reactor design is complete, with no further R&D expected for first-of-a-kind (FOAK) deployment or next-of-a-kind (NOAK) commercialization, and existing capital expected to fully fund licensing, construction, and initial operations
  • End-to-End Supply Chain Secured and Manufacturing Underway

    Terra has secured a full nuclear-grade supply chain and initiated pre-fabrication and manufacturing activities, significantly de-risking deployment timelines and enabling scalable production  
  • Scalable, Asset-Light "Fabless" Manufacturing Model

    The Company's factory-based, partner-driven production strategy is expected to support rapid scaling from hundreds to potentially thousands of units annually over time  
  • Expanding Commercial Traction Across High-Growth End Markets

    Terra is seeing strong demand across data centers, industrial applications, infrastructure, and healthcare, with approximately 200 non-binding pre-commercial unit commitments representing ~$4 billion in potential value  
  • Strategic Positioning in AI Infrastructure and Other Key Energy-Constrained Markets

    Recent commercial initiatives include a pilot deployment supporting next-generation AI data centers, with potential to scale significantly as demand for reliable, behind-the-meter power accelerates  
  • Introduction of High-Value Product Extensions, Including Radioisotopes

    The updated materials highlight SOLO's ability to produce multiple outputs — including electricity, process heat, and radioisotopes — expanding the Company's addressable market into high-margin healthcare and advanced industrial applications  
  • Clear Path from FOAK to Commercial Scale Deployment

    Terra is targeting FOAK deployment beginning in 2027 with commercialization in 2028, supported by a streamlined licensing approach and standardized reactor design